Literature DB >> 33245762

Kinetic modeling of stem cell transcriptome dynamics to identify regulatory modules of normal and disturbed neuroectodermal differentiation.

Johannes Meisig1,2, Nadine Dreser3, Marion Kapitza3, Margit Henry4,5, Tamara Rotshteyn4,5, Jörg Rahnenführer6, Jan G Hengstler7, Agapios Sachinidis4,5, Tanja Waldmann3, Marcel Leist3, Nils Blüthgen1,2.   

Abstract

Thousands of transcriptome data sets are available, but approaches for their use in dynamic cell response modelling are few, especially for processes affected simultaneously by two orthogonal influencing variables. We approached this problem for neuroepithelial development of human pluripotent stem cells (differentiation variable), in the presence or absence of valproic acid (signaling variable). Using few basic assumptions (sequential differentiation states of cells; discrete on/off states for individual genes in these states), and time-resolved transcriptome data, a comprehensive model of spontaneous and perturbed gene expression dynamics was developed. The model made reliable predictions (average correlation of 0.85 between predicted and subsequently tested expression values). Even regulations predicted to be non-monotonic were successfully validated by PCR in new sets of experiments. Transient patterns of gene regulation were identified from model predictions. They pointed towards activation of Wnt signaling as a candidate pathway leading to a redirection of differentiation away from neuroepithelial cells towards neural crest. Intervention experiments, using a Wnt/beta-catenin antagonist, led to a phenotypic rescue of this disturbed differentiation. Thus, our broadly applicable model allows the analysis of transcriptome changes in complex time/perturbation matrices.
© The Author(s) 2020. Published by Oxford University Press on behalf of Nucleic Acids Research.

Entities:  

Year:  2020        PMID: 33245762      PMCID: PMC7736781          DOI: 10.1093/nar/gkaa1089

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  80 in total

1.  Model-based method for transcription factor target identification with limited data.

Authors:  Antti Honkela; Charles Girardot; E Hilary Gustafson; Ya-Hsin Liu; Eileen E M Furlong; Neil D Lawrence; Magnus Rattray
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-12       Impact factor: 11.205

2.  The risk of spina bifida aperta after first-trimester exposure to valproate in a prenatal cohort.

Authors:  J G Omtzigt; F J Los; D E Grobbee; L Pijpers; M G Jahoda; H Brandenburg; P A Stewart; H L Gaillard; E S Sachs; J W Wladimiroff
Journal:  Neurology       Date:  1992-04       Impact factor: 9.910

3.  Direct Reprogramming of Human Neurons Identifies MARCKSL1 as a Pathogenic Mediator of Valproic Acid-Induced Teratogenicity.

Authors:  Soham Chanda; Cheen Euong Ang; Qian Yi Lee; Michael Ghebrial; Daniel Haag; Yohei Shibuya; Marius Wernig; Thomas C Südhof
Journal:  Cell Stem Cell       Date:  2019-05-30       Impact factor: 24.633

4.  Gata6, Nanog and Erk signaling control cell fate in the inner cell mass through a tristable regulatory network.

Authors:  Sylvain Bessonnard; Laurane De Mot; Didier Gonze; Manon Barriol; Cynthia Dennis; Albert Goldbeter; Geneviève Dupont; Claire Chazaud
Journal:  Development       Date:  2014-09-10       Impact factor: 6.868

Review 5.  The adult human brain in preclinical drug development.

Authors:  Mike Dragunow
Journal:  Nat Rev Drug Discov       Date:  2008-07-11       Impact factor: 84.694

6.  Differential L1 regulation in pluripotent stem cells of humans and apes.

Authors:  Maria C N Marchetto; Iñigo Narvaiza; Ahmet M Denli; Christopher Benner; Thomas A Lazzarini; Jason L Nathanson; Apuã C M Paquola; Keval N Desai; Roberto H Herai; Matthew D Weitzman; Gene W Yeo; Alysson R Muotri; Fred H Gage
Journal:  Nature       Date:  2013-10-23       Impact factor: 49.962

7.  Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling.

Authors:  Stuart M Chambers; Christopher A Fasano; Eirini P Papapetrou; Mark Tomishima; Michel Sadelain; Lorenz Studer
Journal:  Nat Biotechnol       Date:  2009-03-01       Impact factor: 54.908

8.  Maternal Use of Antiepileptic Agents During Pregnancy and Major Congenital Malformations in Children.

Authors:  Rebecca L Bromley; Jennifer Weston; Anthony G Marson
Journal:  JAMA       Date:  2017-11-07       Impact factor: 56.272

9.  A computational model for understanding stem cell, trophectoderm and endoderm lineage determination.

Authors:  Vijay Chickarmane; Carsten Peterson
Journal:  PLoS One       Date:  2008-10-22       Impact factor: 3.240

10.  RNA velocity of single cells.

Authors:  Gioele La Manno; Ruslan Soldatov; Amit Zeisel; Emelie Braun; Hannah Hochgerner; Viktor Petukhov; Katja Lidschreiber; Maria E Kastriti; Peter Lönnerberg; Alessandro Furlan; Jean Fan; Lars E Borm; Zehua Liu; David van Bruggen; Jimin Guo; Xiaoling He; Roger Barker; Erik Sundström; Gonçalo Castelo-Branco; Patrick Cramer; Igor Adameyko; Sten Linnarsson; Peter V Kharchenko
Journal:  Nature       Date:  2018-08-08       Impact factor: 49.962

View more
  3 in total

1.  Pluripotent stem cell assays: Modalities and applications for predictive developmental toxicity.

Authors:  Aldert H Piersma; Nancy C Baker; George P Daston; Burkhard Flick; Michio Fujiwara; Thomas B Knudsen; Horst Spielmann; Noriyuki Suzuki; Katya Tsaioun; Hajime Kojima
Journal:  Curr Res Toxicol       Date:  2022-05-13

2.  Optimization of the TeraTox Assay for Preclinical Teratogenicity Assessment.

Authors:  Manuela Jaklin; Jitao David Zhang; Nicole Schäfer; Nicole Clemann; Paul Barrow; Erich Küng; Lisa Sach-Peltason; Claudia McGinnis; Marcel Leist; Stefan Kustermann
Journal:  Toxicol Sci       Date:  2022-06-28       Impact factor: 4.109

3.  Valproic acid promotes the in vitro differentiation of human pluripotent stem cells into spermatogonial stem cell-like cells.

Authors:  Xiaotong Wang; Mengyuan Qu; Zili Li; Yuting Long; Kai Hong; Honggang Li
Journal:  Stem Cell Res Ther       Date:  2021-10-29       Impact factor: 6.832

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.